Additionally, a study by Chatterjee, Sushmita, et al. determined that NIS expression was detected in 70% of breast-cancer patients, and NIS activity varied amongst breast-cancer subtypes [10]. This evidence concerns the gene SLC5A5 and breast carcinoma.